Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of mullerian inhibiting substance for treating certain tumors and for modulating class I major histocompatibility antigen expression

Use of mullerian inhibiting substance for treating certain tumors and for modulating class I major histocompatibility antigen expression

US Patent 5661126 · Granted Aug 26, 1997

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified Mullerian Inhibiting Substance (MIS) proteins and uses thereof for the 2025
Mullerian inhibiting substance (MIS) proteins for ovarian and uterine oncoprotec2025
Advanced electrolyte systems and their use in energy storage devices2024
Use of Mullerian inhibiting substance (MIS) proteins for contraception and ovari2024
High temperature energy storage device2024
Advanced electrolyte systems and their use in energy storage devices2023
Mullerian inhibiting substance (MIS) proteins for ovarian and uterine oncoprotec2022
High temperature energy storage device2022
Advanced electrolyte systems and their use in energy storage devices2022
Use of mullerian inhibiting substance (MIS) proteins for contraception and ovari2021
Modified Mullerian inhibiting substance (MIS) proteins and uses thereof for the 2021
High temperature energy storage device2020